Compare OTIS & KVUE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | OTIS | KVUE |
|---|---|---|
| Founded | 1853 | 2022 |
| Country | United States | United States |
| Employees | N/A | 22000 |
| Industry | Consumer Electronics/Appliances | Specialty Chemicals |
| Sector | Technology | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 35.5B | 33.1B |
| IPO Year | N/A | 2023 |
| Metric | OTIS | KVUE |
|---|---|---|
| Price | $87.13 | $17.11 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 8 | 13 |
| Target Price | ★ $103.50 | $20.31 |
| AVG Volume (30 Days) | 2.6M | ★ 36.4M |
| Earning Date | 01-28-2026 | 02-05-2026 |
| Dividend Yield | 1.89% | ★ 4.80% |
| EPS Growth | N/A | ★ 35.31 |
| EPS | ★ 3.39 | 0.75 |
| Revenue | $14,310,000,000.00 | ★ $15,006,000,000.00 |
| Revenue This Year | $3.75 | N/A |
| Revenue Next Year | $4.72 | $2.81 |
| P/E Ratio | $26.27 | ★ $23.11 |
| Revenue Growth | ★ 0.73 | N/A |
| 52 Week Low | $84.25 | $14.02 |
| 52 Week High | $106.83 | $25.17 |
| Indicator | OTIS | KVUE |
|---|---|---|
| Relative Strength Index (RSI) | 44.87 | 56.17 |
| Support Level | $87.48 | $17.14 |
| Resistance Level | $89.46 | $17.48 |
| Average True Range (ATR) | 1.26 | 0.28 |
| MACD | 0.21 | -0.01 |
| Stochastic Oscillator | 41.48 | 52.39 |
Otis is the largest global elevator and escalator supplier by revenue with around 18% global market share. In 1854 Otis' founder and namesake Elisha Graves Otis, invented a safety mechanism that prevented elevators from falling if the hoisting cable failed. The company's product and service lifecycle begins with installations of elevator units in new buildings, later selling maintenance services on the units, and eventually replacement of the units after the average 15- to 20-year useful life of an elevator. As the largest global OEM, Otis has amassed an installed base under service that exceeds 2 million elevators. Its business model is similar to that of its closest competitors Kone, Schindler, and TK Elevator.
Kenvue is the world's largest pure-play consumer health company by sales, generating over $15 billion in annual revenue. Formerly known as Johnson & Johnson's consumer segment, Kenvue spun off and went public in May 2023. It operates in a variety of categories within consumer health, such as cough, cold and allergy care, pain management, face and body care, and oral care, as well as women's health. Its portfolio has some of the most well-known brands in the space, including Tylenol, Listerine, Johnson's, Aveeno, and Neutrogena. Kenvue announced November 2025 that it signed a deal to be fully acquired by Kimberly-Clark with the deal expected to close during the second half of 2026.